Revenue recognition change
beta
Filing comparison
MYOMO, INC. changed its revenue recognition disclosure
The transaction price associated with the MyoPro for direct to patient revenue is generally determined by the insurance payer.
Evidence
- New language
- The transaction price associated with the MyoPro for direct to patient revenue is generally determined by the insurance payer., If a patient has insurance that supplements Medicare Part B with a payer for which sufficient payment history exists or is a non-employer-based plan, the Company estimates the transaction price based on receiving the remaining 20% of the Medicare allowable.
- Prior filed
- 2025-03-10
- Prior form
- 10-K
- Similarity
- 0.532
- Source
- revenue recognition note comparison
- Threshold
- 0.6
- Why
- The revenue recognition policy disclosure changed materially from the previous comparable filing.
Language present now, absent from the prior filing:
- The transaction price associated with the MyoPro for direct to patient revenue is generally determined by the insurance payer.
- If a patient has insurance that supplements Medicare Part B with a payer for which sufficient payment history exists or is a non-employer-based plan, the Company estimates the transaction price based on receiving the remaining 20% of the Medicare allowable.